the synergistic antitumor activity of pan-pi3k inhibition and ici's in bladder cancer
Published 1 year ago • 62 plays • Length 1:36Download video MP4
Download video MP3
Similar videos
-
1:28
immune checkpoint inhibitors and sitravatinib in bladder cancer
-
1:14
how can we continue the success of checkpoint inhibitors for bladder cancer treatment?
-
10:44
earlier use of immune checkpoint inhibitors to adjuvant and non muscle invasive bladder cancer
-
2:01
immune checkpoint inhibitors in urothelial bladder cancer
-
2:01
using checkpoint inhibitors at earlier stages of bladder cancer – the next step in immunotherapy?
-
42:23
bladder cancer | dr. tony talebi discusses "the treatment of stage 1 to 3 bladder cancer?"
-
6:44
pi3k/akt pathway - part 1: overview
-
38:49
the pi3k / akt / mtor pathway and cancer part 1
-
4:43
impact of immune checkpoint inhibitors on care of patients with advanced bladder cancer
-
5:04
pifithrin-α
-
1:00:07
pi3k/akt pathway inhibition for the treatment of metastatic castrate-resistant prostate cancer
-
1:18
the current status of pi3k inhibitors in hematological malignancies and challenges to overcome
-
2:02
pi3k inhibition for r/r follicular lymphoma
-
0:20
class iii pi3k regulates organismal glucose homeostasis by providing negative feedback on hepatic...
-
5:29
real-world performance of checkpoint inhibitor among platinum-ineligible pts with adv bladder cancer
-
1:16
bladder cancer trimodality therapy
-
1:29
the pi3k/akt signaling pathway: a mediator of metastasis in colorectal cancer
-
1:01
david j. mcconkey, phd, provides information on treating bladder cancer with checkpoint inhibitors
-
1:19
restoration of wild-type tp53 in pancreatic cancer | aging-us
-
6:38
case 2: exciting new treatment for cis-ineligible bladder cancer
-
1:45
case 2: i/o therapy for cisplatin-ineligible bladder cancer
-
5:21
the emerging role of pi3k inhibition